Clinical Trial Update: Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS (CLASSIC-MS) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing long-term outcomes and durability of effect after cladribine tablets in multiple sclerosis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Cladribine tablets (cladribine)

Snippet

Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Multiple Sclerosis (MS) | Phase 4 | Status: COMPLETED | Results posted: 2022-05-05